Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2337-2026

Product Name: CORFLO* Safety PEG Kit with ENFit Connector Recall

Product Name: CORFLO* Safety PEG Kit with ENFit¿ Connector Model/Catalog Number: 50-4320

FDA recall Class II

Ongoing

FDA lists this Class II recall for Product Name: CORFLO* Safety PEG Kit with ENFit Connector. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2337-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 30, 2026
FDA report date
Jun 17, 2026
Quantity in commerce
49 kits
Distribution
See key details
FDA cause
Material/Component Contamination

What is being recalled?

Product Name: CORFLO* Safety PEG Kit with ENFit Connector Model/Catalog Number: 50-4320

Affected model & UDI checker

Search the exact identifiers published for Z-2337-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
50-4320Product Name: CORFLO* Safety PEG Kit with ENFit ConnectorCheck source noticeNot specified
Not specifiedProduct Name: CORFLO* Safety PEG Kit with ENFit ConnectorCheck source notice10350770007578
FDA code information

UDI-DI 10350770007578, Lot Numbers 30365230, 30367013, 30373825

View the original FDA recall notice

Why was this product recalled?

Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets.

What actions did Avanos Medical, Inc. take?

On May 1, 2026, Avanaos Medical, Inc. issued a "Urgent: Medical Device Recall" Notification to affected consignees via Email. Avanos asked consignees to take the following actions: 1. Immediately review your inventory and identify any affected product. 1a. Quarantine all affected lots to prevent further use or distribution. 1b. Discontinue use of the affected lidocaine hydrochloride injection 1%, 5 mL and return the entire unused kit to Avanos Medical, Inc. for destruction. 2. This notice needs to be passed on to all those who need to be aware within your organization or functions where the potentially affected devices have been transferred. 3. Complete and return the Customer Response Form as instructed, including identifying whether you have inventory of the affected product available for return. Distributors: 1. Provide customers a copy of this notification. Instruct customers to follow the actions outlined in this letter. 2. Provide refunds or credits to your customers in accordance with your internal processes. 3. Submit an updated Customer Response Form to Avanos to account for product distributed to your customers and to receive applicable replacement product.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology